Publisher: Pharmagellan, LLC
ISBN: 9780998407500
Size: 62.98 MB
Format: PDF, Mobi
Category : Business & Economics
Languages : un
Pages : 138
View: 4246
Book Description: If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.
Forecasting For The Pharmaceutical Industry
Author: Arthur G. Cook
Publisher: CRC Press
ISBN: 1317134117
Size: 16.73 MB
Format: PDF, Kindle
Category : Business & Economics
Languages : en
Pages : 234
View: 383
Book Description: Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as well as the multitude of decision makers and executives who rely on forecasts in their decision making. In virtually every decision, a pharmaceutical executive considers some type of forecast. This process of predicting the future is crucial to many aspects of the company - from next month's production schedule, to market estimates for drugs in the next decade. The pharmaceutical forecaster needs to strike a delicate balance between over-engineering the forecast - including rafts of data and complex ’black box’ equations that few stakeholders understand and even fewer buy into - and an overly simplistic approach that relies too heavily on anecdotal information and opinion. Arthur G. Cook's highly pragmatic guide explains the basis of a successful balanced forecast for products in development as well as currently marketed products. The author explores the pharmaceutical forecasting process; the varied tools and methods for new product and in-market forecasting; how they can be used to communicate market dynamics to the various stakeholders; and the strengths and weaknesses of different forecast approaches. The text is liberally illustrated with tables, diagrams and examples. The final extended case study provides the reader with an opportunity to test out their knowledge. The second edition has been updated throughout and includes a brand new chapter focusing on specialized topics such as forecasting for orphan drugs and biosimilars.
Publisher: CRC Press
ISBN: 1317134117
Size: 16.73 MB
Format: PDF, Kindle
Category : Business & Economics
Languages : en
Pages : 234
View: 383
Book Description: Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as well as the multitude of decision makers and executives who rely on forecasts in their decision making. In virtually every decision, a pharmaceutical executive considers some type of forecast. This process of predicting the future is crucial to many aspects of the company - from next month's production schedule, to market estimates for drugs in the next decade. The pharmaceutical forecaster needs to strike a delicate balance between over-engineering the forecast - including rafts of data and complex ’black box’ equations that few stakeholders understand and even fewer buy into - and an overly simplistic approach that relies too heavily on anecdotal information and opinion. Arthur G. Cook's highly pragmatic guide explains the basis of a successful balanced forecast for products in development as well as currently marketed products. The author explores the pharmaceutical forecasting process; the varied tools and methods for new product and in-market forecasting; how they can be used to communicate market dynamics to the various stakeholders; and the strengths and weaknesses of different forecast approaches. The text is liberally illustrated with tables, diagrams and examples. The final extended case study provides the reader with an opportunity to test out their knowledge. The second edition has been updated throughout and includes a brand new chapter focusing on specialized topics such as forecasting for orphan drugs and biosimilars.
Biotechnology
Author: Syed Imtiaz Haider
Publisher: CRC Press
ISBN: 1420084496
Size: 15.76 MB
Format: PDF, Mobi
Category : Medical
Languages : en
Pages : 868
View: 2096
Book Description: All manufacturing companies face the daunting task of designing an employee training matrix that meets the gamut of national and international regulatory standards. Answering the call for a one-stop training resource that focuses exclusively on this multi-faceted, high-tech industry, Biotechnology: A Comprehensive Training Guide for the Biotechnolo
Publisher: CRC Press
ISBN: 1420084496
Size: 15.76 MB
Format: PDF, Mobi
Category : Medical
Languages : en
Pages : 868
View: 2096
Book Description: All manufacturing companies face the daunting task of designing an employee training matrix that meets the gamut of national and international regulatory standards. Answering the call for a one-stop training resource that focuses exclusively on this multi-faceted, high-tech industry, Biotechnology: A Comprehensive Training Guide for the Biotechnolo
The Chemical And Pharmaceutical Industry In China
Author: G. Festel
Publisher: Springer Science & Business Media
ISBN: 3540265619
Size: 28.87 MB
Format: PDF, ePub, Mobi
Category : Business & Economics
Languages : en
Pages : 296
View: 1826
Book Description: A detailed examination of China’s increasingly important chemical and pharmaceutical industry. Numerous case studies describe how western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China.
Publisher: Springer Science & Business Media
ISBN: 3540265619
Size: 28.87 MB
Format: PDF, ePub, Mobi
Category : Business & Economics
Languages : en
Pages : 296
View: 1826
Book Description: A detailed examination of China’s increasingly important chemical and pharmaceutical industry. Numerous case studies describe how western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China.
Biotechnology Valuation
Author: Karl Keegan
Publisher: John Wiley & Sons
ISBN: 0470741341
Size: 30.74 MB
Format: PDF, ePub, Mobi
Category : Business & Economics
Languages : en
Pages : 216
View: 1413
Book Description: The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them Praise for Biotechnology Valuation "Keegan states that the valuation of Biotech companies is as much an art as a science. This brief but comprehensive review of the skills and knowledge required, not of just the financial market and sentiment, but also of the technical attributes of a company and the drug development and regulatory hurdles that must be overcome, highlights the importance of the breadth of understanding required. Biotech investing is not for the timid, but it can bring substantial returns. Keegan's book, punctuated with his personal experience and opinions, is a good place to start." —Chris Blackwell, Chief Executive, Vectura Group plc "A user-friendly, yet thorough discussion of a notoriously difficult topic. Dr Keegan's book is a fine resource for both business types and academicians." —Steve Winokur, Managing Director, CanaccordAdams "A highly readable and comprehensive explanation of the technical and commercial parameters that influence biotechnology companies at all stages of development, providing clear context for selection from the toolkit of valuation methodologies the author recommends to assess company and product performance, or ascribe value." —Dr L.M. Allan, Director, Bioscience Enterprise Programme, University of Cambridge "A fabulous approach to a difficult topic." —Deirdre Y. Gillespie, MD, President & CEO, La Jolla Pharmaceutical Company
Publisher: John Wiley & Sons
ISBN: 0470741341
Size: 30.74 MB
Format: PDF, ePub, Mobi
Category : Business & Economics
Languages : en
Pages : 216
View: 1413
Book Description: The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them Praise for Biotechnology Valuation "Keegan states that the valuation of Biotech companies is as much an art as a science. This brief but comprehensive review of the skills and knowledge required, not of just the financial market and sentiment, but also of the technical attributes of a company and the drug development and regulatory hurdles that must be overcome, highlights the importance of the breadth of understanding required. Biotech investing is not for the timid, but it can bring substantial returns. Keegan's book, punctuated with his personal experience and opinions, is a good place to start." —Chris Blackwell, Chief Executive, Vectura Group plc "A user-friendly, yet thorough discussion of a notoriously difficult topic. Dr Keegan's book is a fine resource for both business types and academicians." —Steve Winokur, Managing Director, CanaccordAdams "A highly readable and comprehensive explanation of the technical and commercial parameters that influence biotechnology companies at all stages of development, providing clear context for selection from the toolkit of valuation methodologies the author recommends to assess company and product performance, or ascribe value." —Dr L.M. Allan, Director, Bioscience Enterprise Programme, University of Cambridge "A fabulous approach to a difficult topic." —Deirdre Y. Gillespie, MD, President & CEO, La Jolla Pharmaceutical Company
Biotech Industry
Author: Bryan Bergeron
Publisher: John Wiley & Sons
ISBN: 0471647578
Size: 35.56 MB
Format: PDF, ePub
Category : Business & Economics
Languages : en
Pages : 368
View: 1003
Book Description: "The biotech industry is a complex, rapidly evolving, and criticalindustry. The industry holds great commercial and societal promise,but it is also filled with hype, confusion, and risks. Bergeron andChan do a remarkable job of providing a sweeping insightful, andprobing assessment of the current state and likely evolution ofthis global industry. This book is essential reading for theexecutive who desires a thorough understanding of this business andits potential."--John P. Glasser, Vice President and ChiefInformation Offers, Partners Healthcare System, Inc. "Bergeron and Chan have done a marvelous job integrating manydifferent perspectives to give the reader a coherent road map ofthe biotech industry for the next decade. This powerful book isanchored by numerous relevant examples that create a frameworkwhich any life sciences professional needs to understand. Ofparticular note is the compelling assessment of the IT industry andits impact on the life sciences as these industriesconverge."--Michael A. Greeley, Managing General Partner, IDGVentures. An in-depth examination of the growth and financing of thebiotechnology industry worldwide Biotech Industry: A Global, Economic, and Financing Overviewprovides a thorough look at the current state of the biotechnologyindustry, including where major research is being conducted, whereit's being applied, and where money and intellectual capital areflowing. Written by a renowned business columnist and an entrepreneurialscientist in the biotech area, this unique book gives Eos and othersenior-level managers an understanding of Asia's pivotal role inthe worldwide success of biotechnology commercialization, as wellas insight into the biotech market over the next decade.
Publisher: John Wiley & Sons
ISBN: 0471647578
Size: 35.56 MB
Format: PDF, ePub
Category : Business & Economics
Languages : en
Pages : 368
View: 1003
Book Description: "The biotech industry is a complex, rapidly evolving, and criticalindustry. The industry holds great commercial and societal promise,but it is also filled with hype, confusion, and risks. Bergeron andChan do a remarkable job of providing a sweeping insightful, andprobing assessment of the current state and likely evolution ofthis global industry. This book is essential reading for theexecutive who desires a thorough understanding of this business andits potential."--John P. Glasser, Vice President and ChiefInformation Offers, Partners Healthcare System, Inc. "Bergeron and Chan have done a marvelous job integrating manydifferent perspectives to give the reader a coherent road map ofthe biotech industry for the next decade. This powerful book isanchored by numerous relevant examples that create a frameworkwhich any life sciences professional needs to understand. Ofparticular note is the compelling assessment of the IT industry andits impact on the life sciences as these industriesconverge."--Michael A. Greeley, Managing General Partner, IDGVentures. An in-depth examination of the growth and financing of thebiotechnology industry worldwide Biotech Industry: A Global, Economic, and Financing Overviewprovides a thorough look at the current state of the biotechnologyindustry, including where major research is being conducted, whereit's being applied, and where money and intellectual capital areflowing. Written by a renowned business columnist and an entrepreneurialscientist in the biotech area, this unique book gives Eos and othersenior-level managers an understanding of Asia's pivotal role inthe worldwide success of biotechnology commercialization, as wellas insight into the biotech market over the next decade.
The Biotech Investor S Bible
Author: George Wolff
Publisher: John Wiley & Sons
ISBN: 0471412791
Size: 68.66 MB
Format: PDF
Category : Business & Economics
Languages : en
Pages : 336
View: 7682
Book Description: A one-stop source for investing in biotech-with detailed coverage of the science, the business, the players, and the strategies for one of today's most promising (and volatile) industries To invest in biotech is to invest in the future, and as such, investors need to learn the nuances of the science they're putting their money on. The core asset of biotech companies is knowledge, and sound investment decisions are impossible without an understanding of this complex science. That's where The Biotech Investor's Bible fits in. This much-needed, one-of-a-kind resource simplifies the complex science surrounding the business of biotech and clarifies subtle distinctions within the context of their financial repercussions. The book explains the basics of genetics, patents, and therapies; and teaches investors how to value biotech companies and their state-of-the art products and technology. The Biotech Investor's Bible offers an informative summary of the relatively short history of the industry and provides a comprehensive review of various industry sectors. George Wolff (St. Pete Beach, FL) is a successful consultant advising clients who are investing in biotech stocks. He has assessed well over 150 biotech companies and has issued a number of valuable white papers that have charted the success of the hottest biotech companies.
Publisher: John Wiley & Sons
ISBN: 0471412791
Size: 68.66 MB
Format: PDF
Category : Business & Economics
Languages : en
Pages : 336
View: 7682
Book Description: A one-stop source for investing in biotech-with detailed coverage of the science, the business, the players, and the strategies for one of today's most promising (and volatile) industries To invest in biotech is to invest in the future, and as such, investors need to learn the nuances of the science they're putting their money on. The core asset of biotech companies is knowledge, and sound investment decisions are impossible without an understanding of this complex science. That's where The Biotech Investor's Bible fits in. This much-needed, one-of-a-kind resource simplifies the complex science surrounding the business of biotech and clarifies subtle distinctions within the context of their financial repercussions. The book explains the basics of genetics, patents, and therapies; and teaches investors how to value biotech companies and their state-of-the art products and technology. The Biotech Investor's Bible offers an informative summary of the relatively short history of the industry and provides a comprehensive review of various industry sectors. George Wolff (St. Pete Beach, FL) is a successful consultant advising clients who are investing in biotech stocks. He has assessed well over 150 biotech companies and has issued a number of valuable white papers that have charted the success of the hottest biotech companies.
Value Creation In The Pharmaceutical Industry
Author: Alexander Schuhmacher
Publisher: John Wiley & Sons
ISBN: 3527339132
Size: 76.55 MB
Format: PDF, Docs
Category : Science
Languages : en
Pages : 508
View: 1200
Book Description: This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation. A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes. A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program.
Publisher: John Wiley & Sons
ISBN: 3527339132
Size: 76.55 MB
Format: PDF, Docs
Category : Science
Languages : en
Pages : 508
View: 1200
Book Description: This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation. A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes. A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program.
Continuous Biomanufacturing
Author: Ganapathy Subramanian
Publisher: John Wiley & Sons
ISBN: 3527340637
Size: 26.30 MB
Format: PDF, Mobi
Category : Science
Languages : en
Pages : 628
View: 6945
Book Description: This is the most comprehensive treatise of this topic available, providing invaluable information on the technological and economic benefits to be gained from implementing continuous processes in the biopharmaceutical industry. Top experts from industry and academia cover the latest technical developments in the field, describing the use of single-use technologies alongside perfusion production platforms and downstream operations. Special emphasis is given to process control and monitoring, including such topics as 'quality by design' and automation. The book is supplemented by case studies that highlight the enormous potential of continuous manufacturing for biopharmaceutical production facilities.
Publisher: John Wiley & Sons
ISBN: 3527340637
Size: 26.30 MB
Format: PDF, Mobi
Category : Science
Languages : en
Pages : 628
View: 6945
Book Description: This is the most comprehensive treatise of this topic available, providing invaluable information on the technological and economic benefits to be gained from implementing continuous processes in the biopharmaceutical industry. Top experts from industry and academia cover the latest technical developments in the field, describing the use of single-use technologies alongside perfusion production platforms and downstream operations. Special emphasis is given to process control and monitoring, including such topics as 'quality by design' and automation. The book is supplemented by case studies that highlight the enormous potential of continuous manufacturing for biopharmaceutical production facilities.
Biopharmaceutics Modeling And Simulations
Author: Kiyohiko Sugano
Publisher: John Wiley & Sons
ISBN: 1118028686
Size: 76.44 MB
Format: PDF
Category : Medical
Languages : en
Pages : 483
View: 1687
Book Description: A comprehensive introduction to using modeling and simulation programs in drug discovery and development Biopharmaceutical modeling has become integral to the design and development of new drugs. Influencing key aspects of the development process, including drug substance design, formulation design, and toxicological exposure assessment, biopharmaceutical modeling is now seen as the linchpin to a drug's future success. And while there are a number of commercially available software programs for drug modeling, there has not been a single resource guiding pharmaceutical professionals to the actual tools and practices needed to design and test safe drugs. A guide to the basics of modeling and simulation programs, Biopharmaceutics Modeling and Simulations offers pharmaceutical scientists the keys to understanding how they work and are applied in creating drugs with desired medicinal properties. Beginning with a focus on the oral absorption of drugs, the book discusses: The central dogma of oral drug absorption (the interplay of dissolution, solubility, and permeability of a drug), which forms the basis of the biopharmaceutical classification system (BCS) The concept of drug concentration How to simulate key drug absorption processes The physiological and drug property data used for biopharmaceutical modeling Reliable practices for reporting results With over 200 figures and illustrations and a peerless examination of all the key aspects of drug research—including running and interpreting models, validation, and compound and formulation selection—this reference seamlessly brings together the proven practical approaches essential to developing the safe and effective medicines of tomorrow.
Publisher: John Wiley & Sons
ISBN: 1118028686
Size: 76.44 MB
Format: PDF
Category : Medical
Languages : en
Pages : 483
View: 1687
Book Description: A comprehensive introduction to using modeling and simulation programs in drug discovery and development Biopharmaceutical modeling has become integral to the design and development of new drugs. Influencing key aspects of the development process, including drug substance design, formulation design, and toxicological exposure assessment, biopharmaceutical modeling is now seen as the linchpin to a drug's future success. And while there are a number of commercially available software programs for drug modeling, there has not been a single resource guiding pharmaceutical professionals to the actual tools and practices needed to design and test safe drugs. A guide to the basics of modeling and simulation programs, Biopharmaceutics Modeling and Simulations offers pharmaceutical scientists the keys to understanding how they work and are applied in creating drugs with desired medicinal properties. Beginning with a focus on the oral absorption of drugs, the book discusses: The central dogma of oral drug absorption (the interplay of dissolution, solubility, and permeability of a drug), which forms the basis of the biopharmaceutical classification system (BCS) The concept of drug concentration How to simulate key drug absorption processes The physiological and drug property data used for biopharmaceutical modeling Reliable practices for reporting results With over 200 figures and illustrations and a peerless examination of all the key aspects of drug research—including running and interpreting models, validation, and compound and formulation selection—this reference seamlessly brings together the proven practical approaches essential to developing the safe and effective medicines of tomorrow.
